Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
310 GBX | 0.00% | +6.90% | +9.54% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
Financials (USD)
Sales 2024 * | 681M | Sales 2025 * | 836M | Capitalization | 3.32B |
---|---|---|---|---|---|
Net income 2024 * | -109M | Net income 2025 * | -5M | EV / Sales 2024 * | 4.58 x |
Net cash position 2024 * | 199M | Net cash position 2025 * | 306M | EV / Sales 2025 * | 3.61 x |
P/E ratio 2024 * |
-28.7
x | P/E ratio 2025 * |
604
x | Employees | 1,988 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 52.37% |
Latest transcript on HUTCHMED (China) Limited
1 week | +6.90% | ||
Current month | +4.20% | ||
1 month | +14.81% | ||
3 months | +60.62% | ||
6 months | -3.43% | ||
Current year | +9.54% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Guo Su
CEO | Chief Executive Officer | 66 | 04-12-31 |
Chig Fung Cheng
DFI | Director of Finance/CFO | 57 | 08-06-30 |
Michael Shi
CTO | Chief Tech/Sci/R&D Officer | 59 | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Keung To
CHM | Chairman | 72 | 99-12-31 |
Graeme Jack
BRD | Director/Board Member | 73 | 17-02-28 |
Dan Eldar
BRD | Director/Board Member | 70 | 16-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 310 | 0.00% | 17,440 |
24-05-02 | 310 | +3.33% | 261,433 |
24-05-01 | 300 | +0.84% | 75,647 |
24-04-30 | 297.5 | -2.14% | 123,751 |
24-04-29 | 304 | +4.83% | 92,539 |
Delayed Quote London S.E., May 03, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.54% | 3.32B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- HCM Stock